Curated News
By: NewsRamp Editorial Staff
July 15, 2026
Earth Science Tech (ETST) Leverages Telehealth and Peptide Therapies for Growth
TLDR
- Earth Science Tech (ETST) gains a competitive edge through proprietary tech and vertical integration in the booming telehealth and peptide markets.
- ETST operates as a holding company, acquiring businesses in pharmaceuticals and telemedicine, leveraging proprietary IT infrastructure for growth.
- ETST's telehealth services expand healthcare access, aiming to make quality medical care more available and improve patient outcomes.
- Peptide therapies, a focus for ETST, are projected to become a $249 billion industry by 2033, revolutionizing treatment approaches.
Impact - Why it Matters
This news matters because Earth Science Tech is strategically positioning itself in two high-growth sectors—telehealth and peptide therapies—that are reshaping healthcare delivery and treatment. As telehealth becomes a standard care model and peptide therapies gain traction for their clinical effectiveness, ETST’s investments in subsidiaries like DOConsultations and Las Villas Health Care could drive significant value. For investors and patients alike, this signals a shift toward more accessible, technology-driven healthcare solutions that may improve outcomes and reduce costs. Understanding ETST’s vertical integration and proprietary tech gives insight into which companies are leading this transformation.
Summary
Earth Science Tech (OTC: ETST), a strategic holding company actively managing a diversified portfolio of operating businesses in pharmaceuticals, telemedicine, healthcare services, real estate, and select consumer markets, is leveraging its proprietary technology and IT infrastructure to strengthen its market position. The company is capitalizing on the surging demand for peptide therapies, a market projected to reach $249 billion by 2033, and the rapidly expanding telehealth industry, which is expected to be valued at $251.5 billion by 2030 with an 11.3% CAGR. Through its subsidiaries, including DOConsultations LLC and Las Villas Health Care Inc., ETST is tapping into these high-growth sectors by offering innovative telemedicine and peptide-based therapeutic solutions.
ETST’s success is built on its proprietary tech and IT infrastructure, providing a significant competitive edge. The company continues to push innovative tech development and expand vertical integration, enabling it to identify and capitalize on unique market opportunities. By acquiring and actively managing businesses that align with these trends, ETST is steadily growing its market share. The company’s focus on telehealth and peptide therapies positions it at the forefront of two transformative industries, with the potential to revolutionize patient care and treatment outcomes.
Investors can stay updated on ETST’s latest developments through the company’s newsroom at https://ibn.fm/ETST. For more detailed information, the full press release is available via InvestorWire, a specialized communications platform that syndicates press releases to over 5,000 outlets. InvestorWire is part of the Dynamic Brand Portfolio @ IBN, which provides enhanced press release distribution, social media reach, and corporate communications solutions to maximize visibility for public companies like Earth Science Tech.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Earth Science Tech (ETST) Leverages Telehealth and Peptide Therapies for Growth
